Condition
Whole Genome Sequencing clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Whole Genome Sequencing clinical trials that are recruiting, at sites in 4 countries (most in United States (2), South Korea (1), Taiwan (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Whole Genome Sequencing clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Routine shallow-coverage Whole Genome Sequencing of Cervical Smears to See if Ovarian Cancer is Found Earlier | — | Toulouse | Recruiting | Sep 16, 2026 |
| Collecting clinical and genomic data to diagnose rare inherited cardiomyopathy | — | Seoul | Recruiting | Apr 29, 2025 |
| Enhancing collaboration for genetic disease diagnosis in critically ill infants | — | Taipei | Recruiting | Feb 12, 2025 |
| Using whole genome sequencing to improve diagnosis in myelodysplastic syndromes | — | St Louis, Missouri | Recruiting | Jun 28, 2022 |
| Using whole genome sequencing to improve diagnosis in blood cancers | — | St Louis, Missouri | Recruiting | Aug 3, 2021 |
All recruiting trials (5)
-
Routine shallow-coverage Whole Genome Sequencing of Cervical Smears to See if Ovarian Cancer is Found Earlier
Researchers test whether analyzing DNA from cervical smears with shallow whole-genome sequencing can help detect high-grade serous ovarian cancer early in patients undergoing treatment for this cancer.
-
Collecting clinical and genomic data to diagnose rare inherited cardiomyopathy
This study is trying to collect health information and genetic data from people with cardiomyopathy to better understand and diagnose this heart condition, especially when regular tests don’t give clear results.
-
Enhancing collaboration for genetic disease diagnosis in critically ill infants
This study is testing whether a new genetic testing method can help doctors quickly diagnose genetic diseases in critically ill infants to provide them with the right treatment sooner.
-
Using whole genome sequencing to improve diagnosis in myelodysplastic syndromes
This study is testing if a new genetic testing method can help doctors diagnose myelodysplastic syndromes better than the usual methods.
-
Using whole genome sequencing to improve diagnosis in blood cancers
This study is testing if a new genetic testing method can help doctors diagnose blood cancers like acute myeloid leukemia and myelodysplastic syndromes more accurately.
Related topics
Quick answers
How many Whole Genome Sequencing clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), South Korea (1 trial), Taiwan (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.